The argument advanced by this essay is, I must warn you, flawed in many ways. It was not written in the hope that you, dear Scholar, would upon finishing it nod your head and say “that was correct”. Rather, this essay has been crafted in the hope that you will finish it and say “that was interesting”.
On Making Research Pay For Itself
Written by The Tatler
For the last 11 years, an intense legal battle has been going on regarding who gets to own – and therefore profit from – a technology developed on a foundation of publicly funded academic research. CRISPR-Cas9 is a technology capable of editing genes within living organisms; potential applications of the technology range from personalized medicine to drought resistant corn and everything in-between. The intellectual property while under patent is worth billions annually in licensing fees – hence the prolonged fighting over it. Once the patent expires and the technology enters the public domain, its value is not likely to drop.
